$3,850.00 – $5,850.00
Published on: January 15, 2023The global market for drug discovery informatics is projected to hit USD 3.64 billion in 2024, rising in the forecast period at CAGR of 10.9%. Rising global R&D spending, growing focus on drug delivery, and the need to monitor the cost of drug discovery and production are the factors driving this market’s growth.
1 Global Drug Discovery Informatics Market
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Drug Discovery Informatics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Drug Discovery Informatics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Drug Discovery Informatics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Drug Discovery Informatics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Drug Discovery Informatics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Drug Discovery Informatics Market – By Process (Market Size – & million/billion)
8.1 Sequencing and Target Data Analysis
8.2 Docking
8.3 Molecular Modelling
8.4 Libraries & Database Preparation
8.5 Other
9 Global Drug Discovery Informatics Market – By Solution
9.1 Software
9.2 Services
10 Global Drug Discovery Informatics Market – By End-User
10.1 Pharmaceutical & Biotechnology Companies
10.2 Contract Research Organizations (CROs)
10.3 Others
11 Global Drug Discovery Informatics Market – By Geography (Market Size – &
million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa
12 Global Drug Discovery Informatics Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships
13 Global Drug Discovery Informatics Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Jubilant Life Sciences
13.3 IBM
13.4 Infosys
13.5 Selvita
13.6 Certara
13.7 Perkinelmer
13.8 Schrödinger
13.9 Dassault Systèmes
13.10 Thermo Fisher Scientific
13.11 Charles River Laboratories
13.12 Company 11 & more
14 Global Drug Discovery Informatics Market – Appendix
14.1 Sources
14.2 Abbreviations
